Aspect Biosystems is a biotechnology company pioneering the development of Bioprinted Tissue Therapeutics (BTTs) to transform how we treat some of the most elusive diseases. Their transformative platform technology integrates proprietary AI-powered bioprinting technology, computational design tools, and therapeutic cells to design tissues that replace, repair, or supplement biological function inside the body.
- Category
- Regenerative Medicine
- Stage
- Series B
- Employees
- 100
- HQ
- Vancouver, Canada
- Founded
- 2013
- Funding
- $260M